image_pdfimage_print

Hydroxychloroquine for Early COVID Studies: Participants Needed

The following is a list of studies using Hydroxychloroquine for early COVID disease compiled from ClinicalTrials.gov on April 24, 2020.

Studies using Hydroxy + Azithromycin:

  • Rutgers, The State University of New Jersey
    Hydroxy + Zith vs Hydroxy alone vs. no treatment
    PCR + with T 100.6 or more
    Inpatient or outpatient
    Recruiting
  • LCMC Health (New Orleans)
    Hydroxy + azith vs. hydroxy alone vs supportive
    Early disease (<7 days of symptoms, PCR +) in 2 groups-
    Early moderate (O2 sat 94+) to severe disease (O2 sat<94)
    Viral load and clinical
    Recruiting

Hydroxy only studies (without azithro):

  • ProgenaBiome (CA-based PCR lab)
    Pre-exposure in health care workers
    Hydroxy + vite C + vite D = Zinc vs. no treatment- no doses listed
  • Baylor
    Hydroxy only
    Pre-exposure professional healthcare workers
    PCR q wk X 7; weeks, enroll by invitation
  • Elizabeth Oelsner, Columbia University
    Hydroxy only; placebo-controlled
    Post-exposure professional to housemates
    Not yet recruiting
  • Hackensack Meridian Health
    Hydroxy only, open-label, no placebo
    Pre-exposure professional health care workers
  • Washington University School of Medicine
    Hydroxy only- testing 3 different doses
    Pre-exposure; healthcare workers
    Not yet recruiting
  • University of Minnesota
    McGill University Health Centre/Research Institute of the McGill University Health Centre
    University of Manitoba
    University of Alberta
    Exposure or early disease <4 days of symptoms
    Hydroxy only vs. Placebo
    Recruiting
  • Montefiore Medical Center
    Early disease, confirmed + or suspect
    Hydroxy only
    Not yet recruiting
  • Providence Health & Services
    Hydroxy vs. Vitamin C
    Early disease- outpatients, PCR + By invitation
  • GeoSentinel Foundation
    Pre-exposure professional health care workers
    Hydroxy vs. placebo
    Not yet recruiting

Thank You Joseph Burrascano, MD for compiling this reference list.

Disclaimer: The Lyme Disease Association Inc. (LDA) provides this information as a public service. LDA does not necessarily endorse any of the studies or recommend participation in any studies. Participants need to review the information on the studies and make their own decisions regarding participation.